Market Research Logo

AMAG Pharmaceuticals Inc (AMAG) - Financial and Strategic SWOT Analysis Review

AMAG Pharmaceuticals Inc (AMAG) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

AMAG Pharmaceuticals Inc (AMAG) is a biopharmaceutical company that develops and commercializes specialty pharmaceutical products. The company focuses on maternal health, anemia management and cancer supportive care. Its marketed products include Makena (hydroxyprogesterone caproate injection) to reduce the risk of preterm birth in women, Feraheme (ferumoxytol) for iron deficiency anemia in adult patients with chronic kidney disease and MuGard Oral Mucoadhesive for the management of oral mucositis and all types of oral wounds including aphthous ulcers/canker sores and traumatic ulcers. AMAG also provides services related to the collection, processing and storage of umbilical cord blood stem cell and cord tissue units. The company offers these products through both direct sales and through network of distributors. It has presence in the US, Switzerland and the UK. AMAG is headquartered in Waltham, Massachusetts, the US.

AMAG Pharmaceuticals Inc Key Recent Developments

Mar 06,2017: AMAG Announces Management Changes and New Commercial Appointments
Feb 14,2017: AMAG Reports Fourth Quarter and Full Year 2016 Financial Results
Jan 09,2017: AMAG Pharmaceuticals Provides Financial and Business Update
Dec 21,2016: AMAG Pharmaceuticals Announces Appointment of Brian Kelley to Board of Directors
Dec 15,2016: AMAG Pharmaceuticals Doubles Support of Prematurity Prevention Research

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
AMAG Pharmaceuticals Inc - Key Facts
AMAG Pharmaceuticals Inc - Key Employees
AMAG Pharmaceuticals Inc - Key Employee Biographies
AMAG Pharmaceuticals Inc - Major Products and Services
AMAG Pharmaceuticals Inc - Pharmaceutical Pipeline Products Data
AMAG Pharmaceuticals Inc, Pipeline Products by Therapy Area
AMAG Pharmaceuticals Inc, Pipeline Products by Development Phase
AMAG Pharmaceuticals Inc - History
AMAG Pharmaceuticals Inc - Company Statement
AMAG Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
AMAG Pharmaceuticals Inc - Business Description
AMAG Pharmaceuticals Inc - Corporate Strategy
AMAG Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
AMAG Pharmaceuticals Inc - Strengths
AMAG Pharmaceuticals Inc - Weaknesses
AMAG Pharmaceuticals Inc - Opportunities
AMAG Pharmaceuticals Inc - Threats
AMAG Pharmaceuticals Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
AMAG Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
AMAG Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
AMAG Pharmaceuticals Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 06, 2017: AMAG Announces Management Changes and New Commercial Appointments
Feb 14, 2017: AMAG Reports Fourth Quarter and Full Year 2016 Financial Results
Jan 09, 2017: AMAG Pharmaceuticals Provides Financial and Business Update
Dec 21, 2016: AMAG Pharmaceuticals Announces Appointment of Brian Kelley to Board of Directors
Dec 15, 2016: AMAG Pharmaceuticals Doubles Support of Prematurity Prevention Research
Nov 03, 2016: AMAG Pharmaceuticals Reports Third Quarter 2016 Financial Results and Provides Corporate Update
Sep 07, 2016: AMAG Pharmaceuticals Appoints Tony Casciano as Senior Vice President of Hematology/Oncology Sales and Marketing
Aug 09, 2016: AMAG Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Corporate Update
Jul 15, 2016: PhRMA Welcomes Five New Member Companies
Jul 12, 2016: AMAG Pharmaceuticals Appoints Mark Stanton as Vice President, Market Access & Corporate Accounts
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
AMAG Pharmaceuticals Inc, Key Facts
AMAG Pharmaceuticals Inc, Key Employees
AMAG Pharmaceuticals Inc, Key Employee Biographies
AMAG Pharmaceuticals Inc, Major Products and Services
AMAG Pharmaceuticals Inc, Number of Pipeline Products by Development Stage
AMAG Pharmaceuticals Inc, History
AMAG Pharmaceuticals Inc, Other Locations
AMAG Pharmaceuticals Inc, Subsidiaries
AMAG Pharmaceuticals Inc, Key Competitors
AMAG Pharmaceuticals Inc, Ratios based on current share price
AMAG Pharmaceuticals Inc
AMAG Pharmaceuticals Inc (Cont...1)
AMAG Pharmaceuticals Inc, Interim Ratios
AMAG Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
AMAG Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
AMAG Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
AMAG Pharmaceuticals Inc, Pipeline Products by Therapy Area
AMAG Pharmaceuticals Inc, Pipeline Products by Development Phase
AMAG Pharmaceuticals Inc, Performance Chart (2012 - 2016)
AMAG Pharmaceuticals Inc, Ratio Charts
AMAG Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
AMAG Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report